Related Experiment Video
Updated: Aug 11, 2026
14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
Clinical trials litigation: practical realities as seen from the trenches
1College of Medicine, University of Tennessee Health Science Center, 956 Court, Suite B328, Memphis, TN 38163, USA. hmorreim@utmem.edu
Accountability in Research
|July 19, 2005
Summary
Litigation in human clinical trials is increasing. This article provides practical insights from a recent lawsuit to help clinical research professionals navigate potential legal challenges.
Area of Science:
- Legal Medicine
- Clinical Research Ethics
- Medical Law
Background:
- Litigation concerning human clinical research trials has significantly increased recently.
- These legal cases present complex theoretical, practical, and human challenges.
- Awareness of these issues is often limited until individuals directly experience them.
Purpose of the Study:
- To offer practical, ground-level observations from a specific clinical trial lawsuit.
- To provide insights potentially useful for clinical research professionals facing similar situations.
- To highlight the human and practical dimensions often overlooked in clinical trial litigation.
Main Methods:
- Case study analysis of a recent lawsuit involving human clinical research.
- Qualitative reflection based on close observation of the legal proceedings.
- Synthesis of practical and human aspects encountered during the litigation process.
Main Results:
- Litigation in clinical research involves significant practical and human impacts beyond theoretical legal questions.
- Direct experience of such lawsuits reveals realities often unknown to those not directly involved.
- Observations underscore the need for preparedness among clinical research personnel.
Conclusions:
- Clinical research professionals should be aware of the escalating litigation risks.
- Understanding the practical and human facets of lawsuits is crucial for preparedness.
- This article serves as a resource, offering lessons learned from a real-world case to aid future navigation of clinical trial litigation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...